Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
AstraZeneca
Merck
Baxter
Mallinckrodt

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Corepharma Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for COREPHARMA, and what generic and branded alternatives to COREPHARMA drugs are available?

COREPHARMA has six approved drugs.

There is one tentative approval on COREPHARMA drugs.

Summary for Corepharma
US Patents:0
Tradenames:6
Ingredients:6
NDAs:6

Drugs and US Patents for Corepharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corepharma LISINOPRIL lisinopril TABLET;ORAL 076102-004 Sep 30, 2002 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Corepharma SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 200263-001 Jun 19, 2012 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Corepharma LISINOPRIL lisinopril TABLET;ORAL 076102-006 Sep 30, 2002 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Corepharma TORSEMIDE torsemide TABLET;ORAL 076894-002 May 31, 2005 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Corepharma LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076674-002 Oct 5, 2004 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
AstraZeneca
Dow
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.